Yuen Wo Tsang
Direttore Tecnico/Scientifico/R&S presso WAI YUEN TONG MEDICINE HOLDINGS LIMITED
Posizioni attive di Yuen Wo Tsang
Società | Posizione | Inizio | Fine |
---|---|---|---|
WAI YUEN TONG MEDICINE HOLDINGS LIMITED | Direttore Tecnico/Scientifico/R&S | 01/09/2018 | - |
Luxembourg Institute of Health
Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Yuen Wo Tsang
Formazione di Yuen Wo Tsang
University of Aston | Undergraduate Degree |
The University of Sydney | Graduate Degree |
Statistiche
Distribuzione geografica
Hong Kong | 2 |
Regno Unito | 2 |
Giappone | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
WAI YUEN TONG MEDICINE HOLDINGS LIMITED | Health Technology |
Aziende private | 1 |
---|---|
Luxembourg Institute of Health
Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Commercial Services |
- Borsa valori
- Insiders
- Yuen Wo Tsang
- Esperienza